Celgene To Snap Up Gloucester Pharma For $640M
By Erin Marie Daly · December 7, 2009, 2:10 PM EST
Biopharmaceutical giant Celgene Corp. revealed plans Monday to acquire privately held Gloucester Pharmaceuticals Inc. in a deal valued at up to $640 million, a move designed to boost Celgene's ability to...
To view the full article, register now.